A Dual‐Bioresponsive Drug‐Delivery Depot for Combination of Epigenetic Modulation and Immune Checkpoint Blockade-Reference-Cited by-同舟云学术

A Dual‐Bioresponsive Drug‐Delivery Depot for Combination of Epigenetic Modulation and Immune Checkpoint Blockade

Published:2019-03-11 Issue:17 Volume:31 Page:1806957
ISSN:0935-9648
Container-title:Advanced Materials
language:en
Short-container-title:Adv. Mater.

Author:

Ruan Huitong¹²³⁴,Hu Quanyin¹³⁴,Wen Di¹³⁴,Chen Qian¹³⁴,Chen Guojun¹³⁴,Lu Yifei¹³⁴,Wang Jinqiang¹³⁴,Cheng Hao⁵,Lu Weiyue²,Gu Zhen¹³⁴^ORCID

Affiliation:

1. Department of BioengineeringUniversity of California Los Angeles CA 90095 USA

2. Department of PharmaceuticsSchool of PharmacyKey Laboratory of Smart Drug DeliveryFudan University Shanghai 201203 China

3. California NanoSystems InstituteJonsson Comprehensive Cancer Center and Center for Minimally Invasive TherapeuticsUniversity of California Los Angeles CA 90095 USA

4. Joint Department of Biomedical EngineeringUniversity of North Carolina at Chapel Hill and North Carolina State University Raleigh NC 27695 USA

5. Department of Materials Science and EngineeringDrexel University Philadelphia PA 19104 USA

Funder

University of North Carolina at Chapel Hill

Alfred P. Sloan Foundation

National Natural Science Foundation of China

China Scholarship Council

Publisher

Wiley

Subject

Mechanical Engineering,Mechanics of Materials,General Materials Science

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/adma.201806957

Reference55 articles.

1. Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunity

2. Anti–PD-1/PD-L1 therapy of human cancer: past, present, and future

3. The future of immune checkpoint therapy

4. Development of immuno-oncology drugs — from CTLA4 to PD1 to the next generations

5. Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy

Cited by 188 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oral biomimetic virus vaccine hydrogel for robust abscopal antitumour efficacy;Journal of Colloid and Interface Science;2024-11

2. Applications of pyroptosis activators in tumor immunotherapy;Materials Today Bio;2024-10

3. Tumor microenvironment-responsive manganese-based nano-modulator activate the cGAS-STING pathway to enhance innate immune system response;Journal of Nanobiotechnology;2024-09-03

4. Two-pronged anti-cancer nanovaccines enpowered by exogenous/endogenous tumor-associated antigens;Journal of Controlled Release;2024-09

5. Wrecking neutrophil extracellular traps and antagonizing cancer-associated neurotransmitters by interpenetrating network hydrogels prevent postsurgical cancer relapse and metastases;Bioactive Materials;2024-09